|
1
|
Lin S, Nickens DJ, Patel M, Wilner KD and
Tan W: Clinical implications of an analysis of pharmacokinetics of
crizotinib coadministered with dexamethasone in patients with
non-small cell lung cancer. Cancer Chemother Pharmacol. 84:203–211.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wong ML, McMurry TL, Stukenborg GJ,
Francescatti AB, Amato-Martz C, Schumacher JR, Chang GJ, Greenberg
CC, Winchester DP, McKellar DP, et al: Impact of age and
comorbidity on treatment of non-small cell lung cancer recurrence
following complete resection: A nationally representative cohort
study. Lung Cancer. 102:108–117. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Liu HF, Liu JS, Deng JH and Wu RR: Role of
XRCC1 gene polymorphisms in non-small cell lung cancer
cisplatin-based chemotherapy, and their effect on clinical and
pathological characteristics. Genet Mol Res: 15, 2016 doi:
10.4238/gmr15049084.
|
|
4
|
Morgensztern D and Govindan R: Adjuvant
chemotherapy for lung cancer: Cisplatin doublets only? J Natl Compr
Canc Netw. 6:277–284. 2008.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Liu Y, Cheng Z, Pang Y, Cui L, Qian T,
Quan L, Zhao H, Shi J, Ke X and Fu L: Role of microRNAs, circRNAs
and long noncoding RNAs in acute myeloid leukemia. J Hematol Oncol.
12(51)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Akella A, Bhattarai S and Dharap A: Long
noncoding RNAs in the pathophysiology of ischemic stroke.
Neuromolecular Med. 21:474–483. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chen R, Piao X, Xiao M, Wang F and Liu L:
Long noncoding RNAs interact with mRNAs: A new perspective on the
mechanism of premature brain injury. Neurosci Lett.
707(134274)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Abedini P, Fattahi A, Agah S, Talebi A,
Beygi AH, Amini SM, Mirzaei A and Akbari A: Expression analysis of
circulating plasma long noncoding RNAs in colorectal cancer: The
relevance of lncRNAs ATB and CCAT1 as potential clinical hallmarks.
J Cell Physiol. 234:22028–22033. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li L, Zhang X, Liu Q, Yin H, Diao Y, Zhang
Z, Wang Y, Gao Y, Ren X, Li J, et al: Emerging role of HOX genes
and their related long noncoding RNAs in lung cancer. Crit Rev
Oncol Hematol. 139:1–6. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yao G, He J, Kong Y, Zhai J, Xu Y, Yang G,
Kong D, Dong F, Shi S, Yang Q and Sun Y: Transcriptional profiling
of long noncoding RNAs and their target transcripts in ovarian
cortical tissues from women with normal menstrual cycles and
primary ovarian insufficiency. Mol Reprod Dev. 86:847–861.
2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li S, Yue XC, Sun CY, Qin HY and Zhang XY:
Prognostic value of long noncoding RNA ROR in patients with cancer
in China: A systematic review and meta-analysis. Medicine
(Baltimore). 98(e15758)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shang AQ, Wang WW, Yang YB, Gu CZ, Ji P,
Chen C, Zeng BJ, Wu JL, Lu WY, Sun ZJ and Li D: Knockdown of long
non-coding RNA PVT1 suppresses cell proliferation and invasion of
colorectal cancer via upregulation of microRNA-214-3p. Am J Physiol
Gastrointest Liver Physiol. 317:G222–G232. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Xu Y, Lin J, Jin Y, Chen M, Zheng H and
Feng J: The miRNA hsa-miR-6515-3p potentially contributes to lncRNA
H19-mediated-lung cancer metastasis. J Cell Biochem.
120:17413–17421. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Xue M, Shi D, Xu G and Wang W: The long
noncoding RNA linc00858 promotes progress of lung cancer through
miR-3182/MMP2 axis. Artif Cells Nanomed Biotechnol. 47:2091–2097.
2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Feng J, Ma J, Liu S, Wang J and Chen Y: A
noncoding RNA LINC00504 interacts with c-Myc to regulate tumor
metabolism in colon cancer. J Cell Biochem. 120:14725–14734.
2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yang JR, Shi MX and Zeng Y: lncRNA
HAND2-AS1 inhibits proliferation and promotes apoptosis of chronic
myeloid leukemia cells by sponging with micRNA-1275. Eur Rev Med
Pharmacol Sci. 23:2103–2111. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhang X, Zhang W, Jiang Y, Liu K, Ran L
and Song F: Identification of functional lncRNAs in gastric cancer
by integrative analysis of GEO and TCGA data. J Cell Biochem.
120:17898–17911. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhao HL, Xu SQ, Li Q, Zhao YB, Li X and
Yang MP: Long noncoding RNA MIAT promotes the growth and metastasis
of non-small cell lung cancer by upregulating TDP43. Eur Rev Med
Pharmacol Sci. 23:3383–3389. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhao J and Liu HR: Down-regulation of long
noncoding RNA DLX6-AS1 defines good prognosis and inhibits
proliferation and metastasis in human epithelial ovarian cancer
cells via Notch signaling pathway. Eur Rev Med Pharmacol Sci.
23:3243–3252. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhao H, Wang Y and Ren X: Nicotine
promotes the development of non-small cell lung cancer through
activating LINC00460 and PI3K/Akt signaling. Biosci Rep.
39(BSR20182443)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Boysen M, Kityk R and Mayer MP: Hsp70- and
Hsp90-mediated regulation of the conformation of p53 DNA binding
domain and p53 cancer variants. Mol Cell. 74:831–843.e4.
2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mackay HL, Moore D, Hall C, Birkbak NJ,
Jamal-Hanjani M, Karim SA, Phatak VM, Pinon L, Morton JP, Swanton
C, et al: Genomic instability in mutant p53 cancer cells upon
entotic engulfment. Nat Commun. 9(3070)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Mackay HL, Moore D, Hall C, Birkbak NJ,
Jamal-Hanjani M, Karim SA, Phatak VM, Pinon L, Morton JP, Swanton
C, et al: Publisher correction: Genomic instability in mutant p53
cancer cells upon entotic engulfment. Nat Commun.
9(3540)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang X, Qi Z, Yin H and Yang G:
Interaction between p53 and Ras signaling controls cisplatin
resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis
and autophagy. Theranostics. 9:1096–1114. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Jiang W, Chen Y, Song X, Shao Y, Ning Z
and Gu W: Pim-1 inhibitor SMI-4a suppresses tumor growth in
non-small cell lung cancer via PI3K/AKT/mTOR pathway. Onco Targets
Ther. 12:3043–3050. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li F, Zhao S, Guo T, Li J and Gu C: The
nutritional cytokine leptin promotes NSCLC by activating the
PI3K/AKT and MAPK/ERK pathways in NSCLC cells in a paracrine
manner. Biomed Res Int. 2019(2585743)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ling C, Wang X, Zhu J, Tang H, Du W, Zeng
Y, Sun L, Huang JA and Liu Z: MicroRNA-4286 promotes cell
proliferation, migration, and invasion via PTEN regulation of the
PI3K/Akt pathway in non-small cell lung cancer. Cancer Med.
8:3520–3531. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Shen WM, Yin JN, Xu RJ, Xu DF and Zheng
SY: Ubiquitin specific peptidase 49 inhibits non-small cell lung
cancer cell growth by suppressing PI3K/AKT signaling. Kaohsiung J
Med Sci. 35:401–407. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang J, Wang HY, Shen Y, Liang D, Wang HY,
Zhang SQ, Cao YX and Cao L: A novel small-molecule PI3K/Akt
signaling inhibitor, W934, exhibits potent antitumor efficacy in
A549 non-small-cell lung cancer. Anticancer Drugs. 30:900–908.
2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wu DM, Zhang T, Liu YB, Deng SH, Han R,
Liu T, Li J and Xu Y: The PAX6-ZEB2 axis promotes metastasis and
cisplatin resistance in non-small cell lung cancer through PI3K/AKT
signaling. Cell Death Dis. 10(349)2019.PubMed/NCBI View Article : Google Scholar
|
